René van der Merwe - Publications, H-index & Citations

René van der Merwe

AstraZeneca

15H指数

43论文数

3.1K被引数

收录论文 11

发表时间

Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2019-04-01

242

OAAI

Simpson, Eric L.; Parnes, Jane R.; She, Dewei; Crouch, Sarah; Rees, William; Mo, May; van der Merwe, Rene

Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2019-01-01

309

OAAI

Wollenberg, Andreas; Howell, Michael D.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Kell, Christopher; Ranade, Koustubh; Moate, Rachel; van der Merwe, Rene

Exposure-response analysis of tezepelumab in patients with severe asthma to guide phase 3 dose selection

EUROPEAN RESPIRATORY JOURNAL

IF21

2018-11-19

PREAI

Ly, Neang; Zheng, Yanan; Griffiths, Janet M.; Van der Merwe, Rene; Agoram, Balaji; Roskos, Lorin

Tezepelumab demonstrates clinically meaningful improvements in asthma control (ACQ-6) in patients with uncontrolled asthma: results from a phase 2b clinical trial

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2018-02-01

OAAI

Corren, Jonathan; Parnes, Jane R.; Wang, Liangwei; Mo, May; Roseti, Stephanie L.; Griffiths, Janet M.; O'Quinn, Sean; van der Merwe, Rene

Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study

EUROPEAN RESPIRATORY JOURNAL

IF21

2017-12-06

PREAI

Roseti, Stephanie; Corren, Jonathan; Parnes, Jane; Mo, May; Griffiths, Janet; Wang, Liangwei; Van Der Merwe, Rene

Tezepelumab in Adults with Uncontrolled Asthma

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2017-09-07

558

OAAI

Corren, Jonathan; Parnes, Jane R.; Wang, Liangwei; Mo, May; Roseti, Stephanie L.; Griffiths, Janet M.; van der Merwe, Rene

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study

GASTROENTEROLOGY

IF25.1

2017-07-01

219

OAAI

Sands, Bruce E.; Chen, Jingjing; Feagan, Brian G.; Penney, Mark; Rees, William A.; Danese, Silvio; Higgins, Peter D. R.; Newbold, Paul; Faggioni, Raffaella; Patra, Kaushik; Li, Jing; Klekotka, Paul; Morehouse, Chris; Pulkstenis, Erik; Drappa, Jorn; van der Merwe, Rene; Gasser, Robert A., Jr.

Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia benralizumab对成人COPD伴痰嗜酸性粒细胞增多症患者血嗜碱性粒细胞和血清生物标志物的药效学影响

EUROPEAN RESPIRATORY JOURNAL

IF21

2015-10-30

PREAI

Damera, Gautam; Brightling, Christopher; Bleecker, Eugene; She, Dewei; Van der Merwe, Rene; Ward, Christine

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

LANCET RESPIRATORY MEDICINE

IF32.8

2014-11-01

413

PREAI

Castro, Mario; Wenzel, Sally E.; Bleecker, Eugene R.; Pizzichini, Emilio; Kuna, Piotr; Busse, William W.; Gossage, David L.; Ward, Christine K.; Wu, Yanping; Wang, Bing; Khatry, Deepak B.; van der Merwe, Rene; Kolbeck, Roland; Molfino, Nestor A.; Raible, Donald G.

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

LANCET RESPIRATORY MEDICINE

IF32.8

2014-11-01

248

OAAI

Brightling, Christopher E.; Bleecker, Eugene R.; Panettieri, Reynold A., Jr.; Bafadhel, Mona; She, Dewei; Ward, Christine K.; Xu, Xiao; Birrell, Claire; van der Merwe, Rene

The use of ToF-SIMS and microflotation to assess the reversibility of binding of CMC onto talc

MINERALS ENGINEERING

IF5

2007-08-01

PREAI

Parolis, L. A. S.; van der Merwe, R.; van Leerdam, G. C.; Prins, F. E.; Smeink, R. G.

研究方向